StratNeuro funding for 2024 Collaborative Neuroscience Projects
StratNeuro awards a total of 15 MSEK to support Collaborative Neuroscience Projects.
StratNeuro received 35 letters of intent for the Collaborative Neuroscience Projects and after an internal review, the StratNeuro Board selected the top proposals (approximately 1/3), which were then invited to submit full proposals for a second round of evaluation by an external review panel consisting of Satu Palva and Mart Saarma from Helsinki University, David Engblom from Linköping University and Johan Jakobsson from Lund University.
The awardees are (in alphabetical order according to the main applicant's surname):
- Patrik Ernfors, Department of Medical Biochemistry and Biophysics and Per Svenningsson, Department of Clinical Neuroscience
- Project: "Elucidation of shared neural ensembles for depression and pain"
- Project: "Elucidation of shared neural ensembles for depression and pain"
- Jonas Frisén, Department of Cell and Molecular Biology and Lou Brundin, Department of Clinical Neuroscience
- Project: "Identification of autoreactive B and T cells and their cognate antigens in multiple sclerosis"
- Project: "Identification of autoreactive B and T cells and their cognate antigens in multiple sclerosis"
- Jens Hjerling-Leffler, Department of Medical Biochemistry and Biophysics and Christoph Ziegenhain, Department of Cell and Molecular Biology
- Project: "Cell type-specific changes in mRNA splicing in schizophrenia"
- Johan Lundström, Department of Clinical Neuroscience and Gilad Silberberg, Department of Neuroscience
- Project: "How does breathing shape multisensory integration? A crossspecies approach for studying active sensing in health and disease"
- Project: "How does breathing shape multisensory integration? A crossspecies approach for studying active sensing in health and disease"
- Pete Williams, Department of Clinical Neuroscience and Georgios Sotiriou, Department of Microbiology, Tumor and Cell Biology
- Project: "Nanoparticle-mediated ocular delivery of novel NAD-boosting small molecules for ophthalmic disease"
StratNeuro is committed to transparency and gender equality
The overall success rate was 14.3%. In the first round (35 letters of intent), the proportion of women as main applicants was 17%, which is lower compared to other StratNeuro calls (approx. 33%). From the highest scoring letters of intent that were selected for a full proposal submission, ~17% of main applicants were women. The StratNeuro Board is deeply committed to promote diversity in the neuroscience community and will in future calls encourage a more gender-balanced and diverse pool of applicants.